Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
1.2 USD | +0.84% | -0.83% | -11.76% |
03-21 | North American Morning Briefing : Investors -2- | DJ |
03-14 | AVROBIO, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-11.76% | 53.38M | |
-3.09% | 102B | |
+1.05% | 96.29B | |
+1.78% | 22.18B | |
-15.78% | 21.2B | |
-9.58% | 18.31B | |
-38.74% | 17.38B | |
-13.48% | 16.36B | |
+6.57% | 13.97B | |
+33.68% | 12.17B |
- Stock Market
- Equities
- AVRO Stock
- News AVROBIO, Inc.
- Avrobio : Says FDA Approval of Sanofi's Fabrazyme Leaves Head-to-Head Trial as Best Path for Its Fabry Disease Treatment; Stock Sinks